Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Placement technique impacts gastrostomy tube-related complications amongst head and neck cancer patients.
Forner D, Mok F, Verma N, Karam I, Goldstein D, Higgins K, Enepekides D, Nadler A, Pugash R, Husain Z, Chan K, Smoragiewicz M, Cohen L, Hazey JW, Fung EC, Kang SY, Seim NB, Simpson C, Eskander A. Forner D, et al. Among authors: smoragiewicz m. Oral Oncol. 2022 Jul;130:105903. doi: 10.1016/j.oraloncology.2022.105903. Epub 2022 May 12. Oral Oncol. 2022. PMID: 35569318
The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study.
Ko JJ, Xie W, Kroeger N, Lee JL, Rini BI, Knox JJ, Bjarnason GA, Srinivas S, Pal SK, Yuasa T, Smoragiewicz M, Donskov F, Kanesvaran R, Wood L, Ernst DS, Agarwal N, Vaishampayan UN, Rha SY, Choueiri TK, Heng DY. Ko JJ, et al. Among authors: smoragiewicz m. Lancet Oncol. 2015 Mar;16(3):293-300. doi: 10.1016/S1470-2045(14)71222-7. Epub 2015 Feb 12. Lancet Oncol. 2015. PMID: 25681967
Complementary Medicine Use Amongst Patients with Metastatic Cancer Enrolled in Phase III Clinical Trials.
Wells JC, Sidhu A, Ding K, Smoragiewicz M, Heng DYC, Shepherd FA, Ellis PM, Bradbury PA, Jonker DJ, Siu LL, Gelmon KA, Karapetis C, Shapiro J, Nott L, O'Callaghan CJ, Parulekar WR, Seymour L, Monzon JG. Wells JC, et al. Among authors: smoragiewicz m. Oncologist. 2022 Mar 11;27(3):e286-e293. doi: 10.1093/oncolo/oyac020. Oncologist. 2022. PMID: 35274718 Free PMC article.
Editorial Comment.
Smoragiewicz M, Emmenegger U. Smoragiewicz M, et al. J Urol. 2021 May;205(5):1370. doi: 10.1097/JU.0000000000001568.01. Epub 2021 Mar 11. J Urol. 2021. PMID: 33705221 No abstract available.
Characterizing the impact of lymph node metastases on the survival outcome for metastatic renal cell carcinoma patients treated with targeted therapies.
Kroeger N, Pantuck AJ, Wells JC, Lawrence N, Broom R, Kim JJ, Srinivas S, Yim J, Bjarnason GA, Templeton A, Knox J, Bernstein E, Smoragiewicz M, Lee J, Rini BI, Vaishampayan UN, Wood LA, Beuselinck B, Donskov F, Choueiri TK, Heng DY. Kroeger N, et al. Among authors: smoragiewicz m. Eur Urol. 2015 Sep;68(3):506-15. doi: 10.1016/j.eururo.2014.11.054. Epub 2014 Dec 15. Eur Urol. 2015. PMID: 25524810
30 results